2002
DOI: 10.1007/s00335-002-2188-1
|View full text |Cite
|
Sign up to set email alerts
|

Novel phenotypes identified by plasma biochemical screening in the mouse

Abstract: We used ENU mutagenesis in the mouse for the rapid generation of novel mutant phenotypes for both gene function studies and use as new animal models of human disease (Nolan et al. 2000b). One focus of the program was the development of a blood biochemistry screen. At 8-12 weeks of age, approximately 300 ml of blood was collected from F1 offspring of ENU mutagenized male mice. This yielded approximately 125 ml of plasma, used to perform a profile of 17 standard biochemical tests on an Olympus analyzer. Cohorts … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
56
0
1

Year Published

2004
2004
2018
2018

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 58 publications
(57 citation statements)
references
References 0 publications
0
56
0
1
Order By: Relevance
“…From the toxicology field standard operating protocols (SOPs) were provided from Pfizer, GlaxoSmithKline and Bayer as well as two recent peer reviewed publications from the toxicology field (Mortishire-Smith et al 2004;Poon et al 2005). For functional genomic studies to specifically address the influence of the strain background two papers were chosen that demonstrate the profound influence the genetic background has on the metabolic function and phenotype of a genetically modified organism (Hough et al 2002;Sam et al 2001). Finally a combination of clinical trials and studies of human metabolism where samples have been taken under less strict control of external variables were also considered (Brindle et al 2002;Poston et al 2006;Wolff et al 2004;Siu et al 2006;Townsley et al 2006;Khor et al 2006;Teahan et al 2006).…”
Section: The Analytical Process Used To Generate the Reporting Requirmentioning
confidence: 99%
“…From the toxicology field standard operating protocols (SOPs) were provided from Pfizer, GlaxoSmithKline and Bayer as well as two recent peer reviewed publications from the toxicology field (Mortishire-Smith et al 2004;Poon et al 2005). For functional genomic studies to specifically address the influence of the strain background two papers were chosen that demonstrate the profound influence the genetic background has on the metabolic function and phenotype of a genetically modified organism (Hough et al 2002;Sam et al 2001). Finally a combination of clinical trials and studies of human metabolism where samples have been taken under less strict control of external variables were also considered (Brindle et al 2002;Poston et al 2006;Wolff et al 2004;Siu et al 2006;Townsley et al 2006;Khor et al 2006;Teahan et al 2006).…”
Section: The Analytical Process Used To Generate the Reporting Requirmentioning
confidence: 99%
“…ENU mutagenesis. Procedures used for ENU mutagenesis have been described previously (16,19). Identification of mice with blood glucose phenotypes.…”
Section: Methodsmentioning
confidence: 99%
“…Identification of mice with blood glucose phenotypes. Plasma biochemistry screening procedures that were used to identify mice between 8 and 12 weeks of age with glucose phenotypes in a cohort of ENU mutagenized mice have been described previously (19). Intraperitoneal glucose tolerance test.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations